CA2244675A1 - Preparation pharmaceutique combinee et leur utilisation pour traiter les troubles gynecologiques - Google Patents
Preparation pharmaceutique combinee et leur utilisation pour traiter les troubles gynecologiques Download PDFInfo
- Publication number
- CA2244675A1 CA2244675A1 CA 2244675 CA2244675A CA2244675A1 CA 2244675 A1 CA2244675 A1 CA 2244675A1 CA 2244675 CA2244675 CA 2244675 CA 2244675 A CA2244675 A CA 2244675A CA 2244675 A1 CA2244675 A1 CA 2244675A1
- Authority
- CA
- Canada
- Prior art keywords
- lhrh
- treatment
- administration
- raloxifen
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne une préparation pharmaceutique combinée contenant des analogues de LHRH et des anti-oestrogènes à effet oestrogène tissulo-sélectif. Elle concerne également l'utilisation de cette préparation pharmaceutique combinée pour traiter des troubles gynécologiques, notamment l'endométriose et les myomes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19604231.3 | 1996-01-29 | ||
DE19604231A DE19604231A1 (de) | 1996-01-29 | 1996-01-29 | Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen |
PCT/EP1997/000395 WO1997027863A1 (fr) | 1996-01-29 | 1997-01-29 | Preparation pharmaceutique combinee contenant des analogues de lhrh et des anti-oestrogenes pour traiter des troubles gynecologiques |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2244675A1 true CA2244675A1 (fr) | 1997-08-07 |
Family
ID=29421547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2244675 Abandoned CA2244675A1 (fr) | 1996-01-29 | 1997-01-29 | Preparation pharmaceutique combinee et leur utilisation pour traiter les troubles gynecologiques |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2244675A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011156908A1 (fr) * | 2010-06-16 | 2011-12-22 | Endorecherche, Inc. | Méthodes de traitement prophylactique ou thérapeutique de maladies liées aux œstrogènes |
-
1997
- 1997-01-29 CA CA 2244675 patent/CA2244675A1/fr not_active Abandoned
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011156908A1 (fr) * | 2010-06-16 | 2011-12-22 | Endorecherche, Inc. | Méthodes de traitement prophylactique ou thérapeutique de maladies liées aux œstrogènes |
CN103037862A (zh) * | 2010-06-16 | 2013-04-10 | 恩多研究公司 | 治疗或预防雌激素相关疾病的方法 |
EA026675B1 (ru) * | 2010-06-16 | 2017-05-31 | Эндорешерш, Инк. | Способы лечения или предотвращения эстрогензависимых заболеваний |
CN107693794A (zh) * | 2010-06-16 | 2018-02-16 | 恩多研究公司 | 治疗或预防雌激素相关疾病的方法 |
US11576891B2 (en) | 2010-06-16 | 2023-02-14 | Endorecherche, Inc. | Methods of treating or preventing estrogen-related diseases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2110274C1 (ru) | Способ лечения состояния, зависящего от эстрогенов яичников | |
Reissmann et al. | The LHRH antagonist cetrorelix: a review | |
Diedrich et al. | Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation | |
Shoham et al. | Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone | |
JP2703243B2 (ja) | 避妊薬用としての性ステロイド放出と組合わされた黄体形成ホルモン放出ホルモン組成物の連続放出 | |
US7309691B2 (en) | Combined pharmaceutical preparation containing LHRH-analogous substances and anti estrogens for treating gynaecological disorders | |
US5130137A (en) | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders | |
NO321502B1 (no) | Progestogen-fritt kombinert preparat for behandling av benigne gynekologiske sykdommer | |
WO2000007599A1 (fr) | Prevention de signes ou symptomes d'endometriose | |
US20110306547A1 (en) | Lhrh - antagonists in the treatment of fertility disorders | |
EP0994718B1 (fr) | Antagoniste de gonadoliberine | |
Felberbaum et al. | Will GnRH antagonists assist in the treatment of benign gynaecological diseases? | |
JP4418102B2 (ja) | ジエノゲストを有効成分とする子宮筋腫治療剤 | |
CA2244675A1 (fr) | Preparation pharmaceutique combinee et leur utilisation pour traiter les troubles gynecologiques | |
BARBIERI | Gonadotropin-releasing hormone agonists: treatment of endometriosis | |
BG63363B1 (bg) | Използване на антагонист на gnrh за получаване нафармацевтичен състав за лечение на гонадостероидно зависими заболявания | |
Bergqvist | Current drug therapy recommendations for the treatment of endometriosis | |
AU2002230464A1 (en) | Combination therapy for estrogen-dependent disorders | |
AU761274B2 (en) | Pharmaceutical combination preparation that consists of LHRH-analogues and antiestrogens for treating gynecological disorders | |
Neves-e-Castro et al. | Use of luteinizing hormone-releasing hormone analogs in non-neoplastic gynecologic conditions | |
Hornstein et al. | Endometriosis: Long-term treatment with gonadotropin-releasing hormone agonists | |
Adegoke et al. | GnRH Antagonists in the Treatment of Uterine Fibroids | |
CA2341974A1 (fr) | Antagoniste de l'hormone de liberation des gonadotrophines | |
Helvacioglu | Gonadotropin Releasing Hormone Treatment | |
Gudmundsson et al. | Peptide contraception by inhibition of ovulation with intranasal GnRH superagonist: clinical and metabolic aspects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |